Free Trial
NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

Cardlytics logo
$1.78 -0.09 (-4.57%)
As of 10:29 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cardlytics Stock (NASDAQ:CDLX)

Key Stats

Today's Range
$1.79
$1.86
50-Day Range
$1.44
$2.17
52-Week Range
$1.22
$9.48
Volume
169,170 shs
Average Volume
998,832 shs
Market Capitalization
$93.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Hold

Company Overview

Cardlytics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
78th Percentile Overall Score

CDLX MarketRank™: 

Cardlytics scored higher than 78% of companies evaluated by MarketBeat, and ranked 66th out of 301 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cardlytics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cardlytics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardlytics is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardlytics is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardlytics has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Cardlytics' valuation and earnings.
  • Percentage of Shares Shorted

    15.98% of the float of Cardlytics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 9.2.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 6.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cardlytics does not currently pay a dividend.

  • Dividend Growth

    Cardlytics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.98% of the float of Cardlytics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 9.2.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 6.42%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cardlytics has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Cardlytics this week, compared to 6 articles on an average week.
  • Search Interest

    5 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,847.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Cardlytics is held by insiders.

  • Percentage Held by Institutions

    68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardlytics' insider trading history.
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

CDLX Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Analysts Set Cardlytics, Inc. (NASDAQ:CDLX) PT at $3.50
See More Headlines

CDLX Stock Analysis - Frequently Asked Questions

Cardlytics' stock was trading at $3.71 on January 1st, 2025. Since then, CDLX stock has decreased by 52.2% and is now trading at $1.7750.

Cardlytics, Inc. (NASDAQ:CDLX) issued its quarterly earnings results on Wednesday, November, 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18. The company's revenue for the quarter was down 15.1% on a year-over-year basis.
Read the conference call transcript
.

Cardlytics subsidiaries include these companies: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

Last Earnings
11/06/2024
Today
7/07/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CDLX
Fax
N/A
Employees
500
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$3.50
High Stock Price Target
$5.00
Low Stock Price Target
$2.50
Potential Upside/Downside
+87.7%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$189.30 million
Pretax Margin
-65.41%

Debt

Sales & Book Value

Annual Sales
$278.30 million
Price / Cash Flow
N/A
Book Value
$1.38 per share
Price / Book
1.35

Miscellaneous

Free Float
50,192,000
Market Cap
$97.91 million
Optionable
Optionable
Beta
1.21

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CDLX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners